Laurus Labs Ltd

LAURUSLABS19 Jun 2024
Pharmaceuticals
+2.10 (+0.49%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Laurus Labs
Laurus Labs Ltd
Pharmaceuticals
LAURUSLABS19 Jun 2024
+2.10 (+0.49%)
1D
1M
6M
1Y
5Y
All

Laurus Labs - Share Price & Details

Lowest Today
426
Highest Today
435.5
Today’s Open
432.95
Prev. Close
428.25
52 Week High
471
52 Week Low
328.15
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
18.07%
Upper Circuit
Lower Circuit
P/E TTM
103.64
P/B Ratio
5.51
Traded Value(Cr)
0.00
EPS TTM
4.15
Book value
Dividend
0.09%

Price Performance

-1.96 %
1 Wk
-5.08 %
1 M
11.13 %
3 M
18.07 %
1 Y
-0.62 %
YTD

Traded Volume Movement

Technical Details

Support 3
417
Support 2
422
Support 1
426
Pivot Point :
431
Resistance 1
436
Resistance 2
441
Resistance 3
445

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Laurus Labs Ltd
₹430.35(+2.10/0.49%)
430.35+2.1023,194.4018.07103.645.51
Lupin Ltd
₹1,572.30(-9.15/-0.58%)
1,572.30-9.1571,657.5990.5530.813.48
Ipca Laboratories Ltd
₹1,133.40(-29.45/-2.53%)
1,133.40-29.4528,754.8455.7646.644.53
J B Chemicals & Pharmaceuticals Ltd
₹1,810.45(+9.80/0.54%)
1,810.45+9.8028,100.5554.2951.769.75
Sanofi India Ltd
₹7,190.75(+10.15/0.14%)
7,190.75+10.1516,560.305.0429.2016.32
405.55-6.952,380.80-8.6017.561.48

About Laurus Labs Ltd

Laurus Labs Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 23180.92 crores. It has reported a sales of Rs. 1414.52 crores and a net profit of Rs. 121.32 crores for the quarter ended December 2018. The company management includes Ravindranath Kancherla, CHAVA SATYANARAYANA,VENKATA RAVI KUMAR VANTARAM,Aruna Bhinge,Rajesh Koshy Chandy,Ravindranath Kancherla,Venkata Lakshmana Rao Chunduru,Karnam Sekar,KRISHNA CHAITANYA CHAVA,G Venkateswar Reddy (Laurus Labs Ltd) among others.
Chairman
Ravindranath Kancherla
Registered office
Plot No 21 Jawaharlal Nehru,Pharma City Parawada,Visakhapatnam,Andhra Pradesh,531021
FAX :91-891-3061270
Background
Incorporation Year2005
Face Value₹2
Market Lot1

Latest News

Technical View: Nifty may consolidate before marching towards 24,000
The Nifty 50 index snapped a five-day winning streak, closing 42 points lower at 23,516, forming a bearish candlestick pattern. Despite this, experts expect the index to consolidate and then move northward towards the 23,800-24,000 zone, with immediate support at the 23,400 area, as the overall trend remains positive.
19 Jun 2024 | 05:53 PM
📢 Benchmark indices close marginally flat today; Nifty around 23,550
📈 Domestic benchmark indices closed on a flat note on 19th June,2024
📢 At 3:30 PM, the Sensex gained 36.45 points or 0.5% at 77,337.59, and the Nifty was down by 41.90 points or 0.18% at 23,516.00.
📊Among sectoral, Nifty Bank (⬆️1.90%) turned out to be the best performer while Nifty Infra (⬇️1.77%) saw considerable selling.
19 Jun 2024 | 03:41 PM
📢 Benchmark indices open on a flat note today; Nifty near 23,550
📈 Amid mixed global cues, benchmark indices started on a flat note today.
📊 At 9:16 AM, the Sensex gained 106.60 pts or 0.14% at 77,407.74 and the Nifty was up 22.20 pts or 0.09% at 23,580.10. 📢Chambal Fertilisers (⬆️4.23%), Muthoot Finance (⬆️1.16%) and City Union bank (⬆️1.10%) appeared as the top performers on the Nifty50 at open. Indus Towers, Gland Pharma, ZEE stocks are in focus today.
19 Jun 2024 | 09:23 AM
Indices touch new peaks, Sensex tops 77,000 mark
India's equity benchmarks, Sensex and Nifty, reached new highs, with Sensex closing above 77,000 for the first time, gaining 308.3 points (0.4%) to 77,301.1, and Nifty rising 92.3 points (0.39%) to 23,557.9. Both have gained over 7% since June 4. The Nifty Midcap 150 and Nifty Smallcap 250 indices hit record highs, with foreign portfolio investors buying shares worth ₹2,569 crore.
19 Jun 2024 | 09:15 AM
What to expect from Indian stock market in trade on June 19?
📌Indian benchmark indices, Sensex and Nifty 50, are expected to open higher on Wednesday, with the Gift Nifty indicating a positive start.
📌The Nifty 50 rose 0.39% to close at a record 23,557.90 on Tuesday, with a target of 23,950 in the near term.
📌The Bank Nifty rallied 0.88% to close at 50,441, with a potential target of 51,000.
19 Jun 2024 | 08:45 AM

How to buy Laurus Labs shares on nse?

To buy Laurus Labs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Laurus Labs share price today?

The Laurus Labs shares price on nse is Rs.430.35 today.

What is the market cap of Laurus Labs shares on NSE ?

The company has a market capitalization of Rs.23194.40Cr

What is the PE & PB ratio of Laurus Labs shares ?

PE is 103.64 and PB is 5.51

What is the 52 Week High and Low of Laurus Labs shares?

Laurus Labs stock price high: Rs.471 Laurus Labs stock price low: Rs.328.15

What is the market capitalisation of Laurus Labs Ltd?

The market capitalization of Laurus Labs Ltd is 16447.71 crore. 

 

What is the dividend history of Laurus Labs?

For the last year, ending in March 2022, the company declared a dividend of 100.00% equity, which amounted to Rs. 2 per equity share. For the last 5 years, the company has shown consistency in dividend declaration.

How does Laurus Labs generate revenue?

Laurus Labs primary generation of revenue comes out of its synthesis and active pharmaceutical ingredient business operations. These are known as its API businesses, accounting for over 40% of its entire revenue. 

 What is the growth potential of Laurus Labs?

In the pharmaceutical sector, Laurus Labs has seen growth with its synthesis business and its active pharmaceutical ingredients business growing 210% and 49%, respectively. This has put the company on a journey of future optimism and development. 

 

What is the future outlook for Laurus Labs in the pharmaceutical industry?

In January 2023, the shares of Laurus Labs saw a rise of 5.3%. With a strong boost in demand for its niche businesses that produce the chemicals and other important ingredients required for certain drugs, the future of Laurus Labs looks bright. The company has also made bids for expansion and has shown interest in the purchase of an over 70% stake in Richcore Life Sciences. 

 

What are the major products and services offered by Laurus Labs?

The major products that Laurus Labs produces are specific ingredients and chemicals for drugs, and Hepatitis C and oncology drugs. 

 

What are the key markets and regions where Laurus Labs operates?

The company operates from its headquarters in Hyderabad, India, but has manufacturing and research labs at Bangalore and Visakhapatnam, as well as in Hyderabad itself. It also has an R&D center in the USA. It is a multinational corporation and serves a global platform via its subsidiaries in the USA and Europe. 

 

What is the dividend policy of Laurus Labs?

The company holds a good and consistent track record for hanging out dividends, giving them regularly for the past five years.